CellCyte, Sigma-Aldrich deal

SIAL's SAFC Pharma manufacturing unit will supply CCYG with preclinical batches of CCYG's lead compound, CCG-TH30. The glycoprotein that helps stem cells target the heart is expected to begin Phase I ...